SavedAdd your journal

Journals / Türk Beyin Damar Hastalıkları Dergisi / 2020 / Cilt: 26 - Sayı: 3

INTRAVENOUS THROMBOLYTIC THERAPY EXPERIENCE FOR ISCHEMIC STROKE PATIENTS IN A SECONDARY CARE HOSPITAL

İKİNCİ BASAMAK BİR HASTANEDE İSKEMİK İNME HASTALARINA İNTRAVENÖZ TROMBOLİTİK TEDAVİ DENEYİMİ

Hazal Selvi ÇUBUK
Can ÇUBUK
Ceren EFE
Pages
251–256
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was shown that those with mild and moderate baseline and 1st-- hour NIHSS scores had a better prognosis than those with severe scores (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: This study, aims to show the intravenous thrombolytic therapy (IV-tPA) given to patients with ischemic stroke within the first 4.5 hours to affect prognosis according to demographic, etiological and clinical factors.
📊
Key Findings & Data:METHODS: The study was conducted retrospectively and included 26 acute ischemic stroke patients who only received intravenous thrombolytic therapy in Cankiri State Hospital between January 1, 2019, and January 1, 2020.
💡
Conclusion & Impact:It was shown that those with mild and moderate baseline and 1st-- hour NIHSS scores had a better prognosis than those with severe scores (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: This study, aims to show the intravenous thrombolytic therapy (IV-tPA) given to patients with ischemic stroke within the first 4.5 hours to affect prognosis according to demographic, etiological and clinical factors. METHODS: The study was conducted retrospectively and included 26 acute ischemic stroke patients who only received intravenous thrombolytic therapy in Cankiri State Hospital between January 1, 2019, and January 1, 2020. Demographic information, risk factors, stroke etiologies, symptom to needle time were questioned. First and 24th hours NIHSS scores, pre-stroke, discharge, or first week and third month mRS scores and complications were evaluated. RESULTS: It was determined that demographic, and etiological factors, ischemic stroke types and the time of IV-tPA administration did not affect prognosis in patients (p>0,05). It was shown that those with mild and moderate baseline and 1st-- hour NIHSS scores had a better prognosis than those with severe scores (p

Özet

GİRİŞ ve AMAÇ: Bu çalışmada, iskemik inme geçiren hastalara ilk 4.5 saat içerisinde verilen intravenöz trombolitik tedavinin (IV-tPA), demografik, etyolojik, klinik faktörlere göre prognoza etkisinin gösterilmesi amaçlanmıştır. YÖNTEM ve GEREÇLER: Çalışma retrospektif olarak yapılmış olup, çalışmaya 1 Ocak 2019-1 Ocak 2020 tarihleri arasında Çankırı Devlet Hastanesinde, sadece intravenöz trombolitik tedavi verilen 26 akut iskemik inme hastası dahil edilmiştir. Demografik bilgiler, risk faktörleri, inme etyolojileri, semptom başlangıcı ile trombolitik tedavi veriliş zamanı arasındaki süreleri sorgulandı. Birinci ve 24. saat NIHSS skorları, inme öncesi, taburcu ya da 1. hafta ve 3.ay mRS skorları ve komplikasyonlar değerlendirildi. BULGULAR: Hastaların demografik, etyolojik ve iskemik inme nedenlerinin ve IV-tPA veriliş zamanının prognoza etkisinin olmadığı saptanmıştır (p>0.05). Başlangıç ve 1. saat NIHSS skoru hafif ve orta derecede olanların, ağır derecede skoru olanlara oranla daha iyi prognoza sahip olduğu gösterilmiştir (p

🔖

Cite This Article

ÇUBUK, H. S., ÇUBUK, C., EFE, C. (2022). INTRAVENOUS THROMBOLYTIC THERAPY EXPERIENCE FOR ISCHEMIC STROKE PATIENTS IN A SECONDARY CARE HOSPITAL. Türk Beyin Damar Hastalıkları Dergisi, Cilt: 26 - Sayı: 3, 251–256. https://ajindex.com/articles/620335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990–2013: The GBD 2013 Study. Neuroepidemiology 2015; 45(3): 161-176
  2. Arsava M. Beyin Damar Hastalıkları ve Demans. Ulusal Hastalık Yükü ve Çözümleri 2017; 9
  3. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med 2018; 16; 379(7): 611-622
  4. Toyoda K, Koga M, Iguchi Y, et al. Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society. Neurol Med Chir (Tokyo) 2019; 15; 59(12): 449-491
  5. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35-41
  6. Topcuoglu MA, Arsava EM, Ozdemir AO, et al. Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions. Turk J Neurol 2017; 23: 162-175
  7. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019; 50(12): e344-e418
  8. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60(5): 508-517
  9. Mishra NK, Diener HC, Lyden PD, et al. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 2010; 41(12): 2840- 2848
  10. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 25; 359(13): 1317-1329
  11. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 27; 369(9558): 275-282
  12. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke